Corticosteroid treatment for idiopathic facial nerve paralysis: A meta-analysis

Laryngoscope

Volumn 110, Issue 3, 2000, Pages 335-341

  Ramsey, Mitchell Jay ^a   DerSimonian, Rebecca ^b   Holtel, Michael R ^a   Burgess, Lawrence P A ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

analysis; Bell s palsy; corticosteroids; idiopathic facial nerve paralysis; Meta

Indexed keywords

CORTICOSTEROID; CORTISONE; PREDNISONE;

ARTICLE; BELL PALSY; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; FACIAL NERVE PARALYSIS; FUNCTIONAL ASSESSMENT; HUMAN; META ANALYSIS; MOTOR PERFORMANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; BELL PALSY; CLINICAL TRIALS; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; FACIAL NERVE; FACIAL PARALYSIS; GLUCOCORTICOIDS; HUMANS; PLACEBOS; PREDNISOLONE; PREDNISONE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 0034054280     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-200003000-00001     Document Type: Article

References (57)

1. Hauser WA, Karnes WE, Annis J, Kurland LT. Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971; 46:258-264.
2. Peitersen E. The natural history of Bell's palsy. Am J Otol 1982; 4:107-111.
3. Adour KK, Swanson PJ Jr. Facial paralysis in 403 consecutive patients: emphasis on treatment response in patients with Bell's palsy. Trans Am Acad Ophthalmol Otolaryngol 1971; 75:1284-1301.
4. Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105:371-378.
5. Rosenfeld RM. How to systematically review the medical literature. Otolaryngol Head Neck Surg 1996; 115:53-63.
6. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316:450-455.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7:177-188.
8. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989; 8:141-151.
9. Chalmers TC, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials 1981; 2:31-49.
10. Adour KK, Bell DN, Wingerd J. Bell palsy. Dilemma of diabetes mellitus. Arch Otolaryngol 1974; 99:114-117.
11. Adour KK, Wingerd J. Idiopathic facial paralysis (Bell's palsy): factors affecting severity and outcome in 446 patients. Neurology 1974; 24:1112-1116.
12. Adour KK, Byl FM, Hilsinger RL Jr, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978; 88:787-801.
13. Bryant FL. Intratympanic injection of steroid for treatment of facial paralysis. Laryngoscope 1973; 83:700-706.
14. Devi S, Challenor Y, Duarte N, Lovelace RE. Prognostic value of minimal excitability of facial nerve in Bell's palsy. J Neurol Neurosurg Psychiatry 1978; 41:649-652.
15. Devriese PP. Bell's palsy in children. Acta Otorhinolaryngol Belg 1984; 38:261-267.
16. Devriese PP, Schumacher T, Scheide A, de Jongh RH, Houtkooper JM. Incidence, prognosis and recovery of Bell's palsy. A survey of about 1000 patients (1974-1983). Clin Otolaryngol 1990; 15:15-27.
17. Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84:433-442.
18. Hughes GB. Practical management of Bell's palsy. Otolaryngol Head Neck Surg 1990; 102:658-663.
19. Ing DK. Bell's palsy-a retrospective study. Med J Malaya 1974; 28:248-250.
20. Jarvis JF. A review of 250 cases of Bell's palsy. S Afr Med J 1974; 48:593-596.
21. Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol 1986; 20:622-627.
22. McCafferty GJ. Bell's palsy-a clinical survey. J Otolaryngol Soc Aust 1972; 3:410-413.
23. McGovern FH, Estevez J. Observations on 160 patients with peripheral facial paralysis seen in private practice. Laryngoscope 1978; 88:1427-1438.
24. Prescott CA. Idiopathic facial nerve palsy (the effect of treatment with steroids). J Laryngol Otol 1988; 102:403-407.
25. Prescott CA. Idiopathic facial nerve palsy in children and the effect of treatment with steroids. Int J Pediatr Otorhinolaryngol 1987; 13:257-264.
26. Ramamurthi, Ramamurthi B. Prognosis in Bell's palsy-influence of early treatment. J Indian Med Assoc 1974; 62:281-282.
27. Saito O, Aoyagi M, Tojima H, Koike Y. Diagnosis and treatment for Bell's palsy associated with diabetes mellitus. Acta Otolaryngol Suppl Stockh 1994; 511:153-155.
28. Sellars SL. Idiopathic facial nerve palsy. S Afr Med J 1983; 64:379-381.
29. Thomas MH. Treatment of Bell's palsy with cortisone and other measures. Neurology 1955; 5:882-886.
30. Shafshak TS, Essa AY, Bakey FA. The possible contributing factors for the success of steroid therapy in Bell's palsy: a clinical and electrophysiological study. J Laryngol Otol 1994; 108:940-943.
31. May M, Wette R, Hardin WB Jr, Sullivan J. The use of steroids in Bell's palsy: a prospective controlled study. Laryngoscope 1976; 86:1111-1122.
32. Brown JS. Bell's palsy: a 5 year review of 174 consecutive cases: an attempted double blind study. Laryngoscope 1982; 92:1369-1373.
33. Burgess LP, Yim DW, Lepore ML. Bell's palsy: the steroid controversy revisited. Laryngoscope 1984; 94:1472-1476.
34. Huizing EH, Mechelse K, Staal A. Treatment of Bell's palsy. An analysis of the available studies. Acta Otolaryngol Stockh 1981; 92:115-121.
35. Stankiewicz JA. Steroids and idiopathic facial paralysis. Otolaryngol Head Neck Surg 1983; 91:672-677.
36. Austin JR, Peskind SP, Austin SG, Rice DH. Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone. Laryngoscope 1993; 103:1326-1333.
37. Abraham IL, Oosting J, Hart AA. Bell's palsy: factors affecting the prognosis in 200 patients with reference to hypertension and diabetes mellitus. Clin Otolaryngol 1987; 12:349-355.
38. Adour KK, Wingerd J, Bell DN, Manning JJ, Hurley JP. Prednisone treatment for idiopathic facial paralysis (Bell's palsy). N Engl J Med 1972; 287:1268-1272.
39. Al-Husaini A, Jamal GA, Hilmi AM, Mathur VS. Steroid therapy in Bell's palsy. Int J Clin Pharmacol Ther Toxicol 1986; 24:430-432.
40. De-Diego JI, Prim MP, De-Sarria MJ, Madero R, Gavilan J. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 1998; 108:573-575.
41. Devriese PP. Prednisone in idiopathic facial paralysis (Bell's palsy). ORL J Otorhinolaryngol Relat Spec 1977; 39:257-271.
42. Ekstrand T, Glitterstam K. Bell's palsy-beneficial effect of treatment with adrenocorticotrophic hormone (ACTH) in patients with a poor prognosis. Acta Otolaryngol Stockh 1979; 87:9-15.
43. Hyden D, Roberg M, Forsberg P, et al. Acute "idiopathic" peripheral facial palsy: clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids. Am J Otolaryngol 1993; 14:179-186.
44. Kawai M, Inamura H, Koike Y. On the conservative treatment of Bell's palsy. Acta Otolaryngol Suppl (Stockh) 1988; 446:106-110.
45. Kinishi M, Amatsu M, Hosomi H. Conservative treatment of Bell's palsy with steroids and dextran-pentoxiphylline combined therapy. Eur Arch Otorhinolaryngol 1991; 248:147-149.
46. May M, Klein SR, Taylor FH. Idiopathic (Bell's) facial palsy: natural history defies steroid or surgical treatment. Laryngoscope 1985; 95:406-409.
47. Racic G, Denoble PJ, Sprem N, Bojic L, Bota B. Hyperbaric oxygen as a therapy of Bell's palsy. Undersea Hyperb Med 1997; 24:35-38.
48. Stennert E. Bell's palsy-a new concept of treatment. Arch Otorhinolaryngol 1979; 225:265-268.
49. Stennert E. Pathomechanisms in cell metabolism: a key to treatment of Bell's palsy. Ann Otol Rhinol Laryngol 1981; 90:577-583.
50. Tani M, Kinishi M, Takahara T, Hosomi H, Amatsu M. Medical treatment of Bell's palsy. Oral vs. intravenous administration. Acta Otolaryngol Suppl Stockh 1988; 446:114-118.
51. Taverner D. Cortisone treatment of Bell's palsy. Lancet 1954; 2:1052-1054.
52. Taverner D, Fearnley ME, Kemble F, Miles DW, Peiris OA. Prevention of denervation in Bell's palsy. BMJ 1966; 5484:391-393.
53. Taverner D, Kemble F, Cohen SB. Prognosis and treatment of idiopathic facial (Bell's) palsy. BMJ 1967; 4:581-582.
54. Taverner D, Cohen SB, Hutchinson BC. Comparison of corticotrophin and prednisolone in treatment of idiopathic facial paralysis (Bell's palsy). BMJ 1971; 4:20-22.
55. Watanabe S, Kenmochi M, Kinoshita H, Kato I. Effects of administration of high dose hydrocortisone on Bell's palsy. Acta Otolaryngol Suppl (Stockh) 1996; 522:108-110.
56. Williamson IG, Whelan TR. The clinical problem of Bell's palsy: is treatment with steroids effective? Br J Gen Pract 1996; 46:743-747.
57. Wolf SM, Wagner JH, Davidson S, Forsythe A. Treatment of. Bell palsy with prednisone: a prospective, randomized study. Neurology 1978; 28:158-161.